GAMMANORM

This brand name is authorized in Austria, Brazil, Croatia, Ecuador, Estonia, Finland, France, Ireland, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, UK.

Active ingredients

The drug GAMMANORM contains one active pharmaceutical ingredient (API):

1	Human normal immunoglobulin G UNII 66Y330CJHS - HUMAN IMMUNOGLOBULIN G
	Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. Human normal immunoglobulin contains the IgG antibodies present in the normal population. It is usually prepared from pooled plasma from not fewer than 1000 donors.
	Read more about Human normal immunoglobulin G

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
GAMMANORM Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J06BA01	Immunoglobulins, normal human, for extravascular adm.	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BA Immunoglobulins, normal human
Discover more medicines within J06BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	535318070002907, 535318070003007, 535318070003107, 535318070003207, 535318070003307, 535318070003407
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	92-MBE-0317
EE	Ravimiamet	1192317, 1192328, 1192339, 1283857, 1283868, 1283879, 1638334, 1638345, 1638356, 1638367, 1638378, 1638389, 1638390, 1638402, 1638413, 1638424, 1638435, 1638446
FI	Lääkealan turvallisuus- ja kehittämiskeskus	096169, 096178, 096205, 096215, 478393, 495245
FR	Base de données publique des médicaments	64138003
GB	Medicines & Healthcare Products Regulatory Agency	179766, 179769, 324672, 324676, 324680, 325031
HR	Agencija za lijekove i medicinske proizvode	HR-H-251167379
LT	Valstybinė vaistų kontrolės tarnyba	1055298, 1055299, 1058350, 1058351, 1058352, 1058353, 1073116, 1073117, 1073118, 1073119, 1073120, 1073121, 1073122, 1073123, 1073124, 1073125, 1073126, 1073127
MT	Medicines Authority	MA1219/00401, MA1219/00402, MA1219/00403, MA1219/00404, MA1219/00405, MA1219/00406
NL	Z-Index G-Standaard, PRK	199001, 199028, 199036, 199044, 79502, 87084
NZ	Medicines and Medical Devices Safety Authority	12555
PL	Rejestru Produktów Leczniczych	100162165
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65348001, W65348002, W65348003, W65348004, W65348005, W65348006, W65348007, W65348008, W65348009, W65348010, W65348011, W65348012, W65348013, W65348014, W65348015, W65348016, W65348017, W65348018